The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 29, 2018

Filed:

Nov. 27, 2013
Applicant:

Bioelastics, Inc., Vestavia Hills, AL (US);

Inventors:

Dan W. Urry, Vestavia Hills, AL (US);

Kelley D. Urry, Vestavia Hills, AL (US);

Assignee:

BIOELASTICS, INC., Vestavia Hills, AL (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G01N 31/00 (2006.01); G06F 19/00 (2018.01); C12Q 1/02 (2006.01); G01N 33/50 (2006.01); A61K 9/51 (2006.01); A61K 31/555 (2006.01); A61K 47/69 (2017.01);
U.S. Cl.
CPC ...
G01N 33/502 (2013.01); A61K 9/5169 (2013.01); A61K 31/555 (2013.01); A61K 47/6935 (2017.08); Y02A 90/26 (2018.01);
Abstract

Methods to determine drug hydrophobicity and to quantify changes in drug hydrophobicity that optimize drug function by means of differential scanning calorimetry of an endothermic phase transition of a base protein-based polymer, specifically of an elastic-contractile model protein, to which is attached the drug to be evaluated for its hydrophobicity in terms of the change in Gibbs free energy for hydrophobic association, ΔGhave been developed. Also described herein is the preparation of nanoparticles comprised of protein-based polymers, specifically of elastic-contractile model proteins, designed for the binding and desired release rate of a specific drug or class of drugs. Further described herein is a means of targeting the drug-laden nanoparticle to a cell by means of decorating the nanoparticle surface with a molecular entity that selectively binds to the diseased cell or disease causing organism, e.g., by decorating the drug-laden nanoparticle surface with synthetic antigen-binding fragment to an up-regulated receptor characteristic of the diseased cell.


Find Patent Forward Citations

Loading…